Li DF, Guo XJ, Song SP, Li HB. Rare massive hepatic hemangioblastoma: A case report. World J Gastrointest Oncol 2022; 14(12): 2415-2421 [PMID: 36568941 DOI: 10.4251/wjgo.v14.i12.2415]
Corresponding Author of This Article
Hong-Bing Li, MD, MMed, Associate Chief Physician, Department of Radiology, Fuyong People’s Hospital of Shenzhen Baoan, No. 81 Defeng Road, Fuyong Street, Baoan District, Shenzhen 518103, Guangdong Province, China. lihongbing.2@163.com
Research Domain of This Article
Radiology, Nuclear Medicine & Medical Imaging
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Dec 15, 2022; 14(12): 2415-2421 Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2415
Rare massive hepatic hemangioblastoma: A case report
De-Fu Li, Xue-Jun Guo, Shi-Peng Song, Hong-Bing Li
De-Fu Li, Hong-Bing Li, Department of Radiology, Fuyong People’s Hospital of Shenzhen Baoan, Shenzhen 518103, Guangdong Province, China
Xue-Jun Guo, Department of Radiology, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China
Shi-Peng Song, Department of Hepatobiliary Surgery, Fuyong People’s Hospital of Shenzhen Baoan, Shenzhen 518103, Guangdong Province, China
Author contributions: Li DF contributed to the methodology and original draft writing; Guo XJ and Song SP were involved in the data curation and editing the manuscript; Li DF and Li HB contributed to the formal analysis; Guo XJ and Li HB participated in the manuscript writing and review.
Informed consent statement: The local institutional review board of Fuyong People’s Hospital of Shenzhen Baoan approved the study and waived the need for written informed consent due to the study’s retrospective design.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Received: August 30, 2022 Peer-review started: August 30, 2022 First decision: September 23, 2022 Revised: October 2, 2022 Accepted: November 6, 2022 Article in press: November 6, 2022 Published online: December 15, 2022
Abstract
BACKGROUND
Hepatic hemangioblastoma is an extremely rare disease; only three cases have been reported in the literature, and its magnetic resonance imaging (MRI) findings are unreported.
CASE SUMMARY
We report a case of incidental hepatic hemangioblastoma. The patient had no history of von Hippel-Lindau disease or associated clinical signs. Computed tomography and MRI showed a large tumor occupying almost half of the right side of the liver with expansive growth, well-defined borders, heterogeneous mildly progressive enhancement, and visibly enlarged blood supply vessels. Flow voids were observed on T2-weighted imaging. Both diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) map findings of the mass were predominantly inhomogeneous. Postoperative pathology indicated a diagnosis of hemangioblastoma.
CONCLUSION
Enlarged peripheral blood-supplying vessels and progressive enhancement seem to be typical imaging features of hepatic hemangioblastoma. However, a solid significantly enhanced mass with a low signal on DWI and a high signal on ADC may also be helpful for the diagnosis of hepatic hemangioblastoma.
Core Tip: Hepatic hemangioblastoma is mostly huge in size, and images of flow void vessels within the tumor can be seen on T2-weighted imaging, and enlarged peripheral blood-supplying vessels and progressive enhancement seem to be typical imaging features of hepatic hemangioblastoma. However, a solid significantly enhanced mass with a low signal on diffusion-weighted imaging and a high signal on apparent diffusion coefficient may also be helpful for the diagnosis of hepatic hemangioblastoma.
